Back to User profile » Dr Jingjing Zhao

Papers published by Dr Jingjing Zhao:


Apatinib Combined with Irinotecan in the Treatment of Advanced Small-Cell Esophageal Carcinoma: A Case Report

Guo L, Zou X, Gu Y, Yi L, Zhao J, Wu G

OncoTargets and Therapy 2021, 14:1989-1995

Published Date: 18 March 2021

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

Liu Y, Zhao JJ, Zhou ZQ, Pan QZ, Zhu Q, Tang Y, Xia JC, Weng DS

Cancer Management and Research 2019, 11:6691-6702

Published Date: 18 July 2019

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

Zhao JJ, Zhou ZQ, Wang P, Chen CL, Liu Y, Pan QZ, Zhu Q, Tang Y, Weng DS, Xia JC

Cancer Management and Research 2018, 10:6457-6468

Published Date: 28 November 2018

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X

Cancer Management and Research 2018, 10:2141-2150

Published Date: 19 July 2018

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure

Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X

OncoTargets and Therapy 2018, 11:2439-2443

Published Date: 1 May 2018